SillaJen, Inc. (KOSDAQ: A215600)
Health Care · Biotechnology · KR
₩2,340.00
-0.85% today · -25.0% 1Y
SillaJen, Inc. (KOSDAQ: A215600) operates in the Biotechnology industry within the Health Care sector. The company is valued at $241.16M.
Over the last twelve months the share price has lost 25.0%, trading between 1.78K and 5.40K.
Tweenvest scores SillaJen, Inc. across four factors: quality 50/100, value 52/100. Its strongest factor is value.
A215600 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $241.16M
- Revenue (TTM)
- $6.96M
- P/E
- —
- EPS
- -174.50
- Dividend yield
- —
- Beta (5Y)
- 0.06
- 52-week high
- ₩5,400.00
- 52-week low
- ₩1,780.00
- Avg volume (3M)
- —
- Shares outstanding
- 138.55M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Oryzon Genomics S.A.BME: ORY | $243.20M | €2.65 | +0.76% |
| Polaris GroupTWSE: 6550 | $242.78M | NT$16.70 | -0.30% |
| Greenwich LifeSciences, Inc.NasdaqCM: GLSI | $242.63M | $16.53 | -2.65% |
| Pyxis Oncology, Inc.NasdaqGS: PYXS | $242.50M | $2.03 | -5.14% |
| MacroGenics, Inc.NasdaqGS: MGNX | $238.24M | $3.74 | +5.35% |
| Keros Therapeutics, Inc.NasdaqGM: KROS | $236.93M | $11.95 | +5.19% |
| Sutro Biopharma, Inc.NasdaqGM: STRO | $236.61M | $14.27 | -7.04% |
| Camp4 Therapeutics CorporationNasdaqGM: CAMP | $236.58M | $3.77 | -5.75% |
Figures last refreshed Oct 11, 2026.